Sirio Pharma (300791) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.035x

Based on the latest financial reports, Sirio Pharma (300791) has a cash flow conversion efficiency ratio of 0.035x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥101.61 Million ≈ $14.87 Million USD) by net assets (CN¥2.91 Billion ≈ $425.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300791 equity financing ratio to measure how much of total assets are equity-financed.

Sirio Pharma - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sirio Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300791 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Sirio Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sirio Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
XiAn Tian He Defense Technology Co Ltd SHE:300397	-0.012x
Hudson Pacific Properties Inc NYSE:HPP	0.010x
Hangzhou Youngsun Intelligent SHG:603901	0.062x
Guoguang Electric Co Ltd Chengdu SHG:688776	-0.019x
McCormick & Company Incorporated NYSE:MKC-V	0.007x
Henan Senyuan Electric Co Ltd SHE:002358	-0.002x
Clairvest Group Inc. TO:CVG	0.068x
Magazine Luiza S.A SA:MGLU3	0.400x

Annual Cash Flow Conversion Efficiency for Sirio Pharma (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sirio Pharma from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Sirio Pharma stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.64 Billion ≈ $386.49 Million	CN¥566.97 Million ≈ $82.97 Million	0.215x	+42.68%
2023-12-31	CN¥2.57 Billion ≈ $375.51 Million	CN¥386.08 Million ≈ $56.50 Million	0.150x	-8.63%
2022-12-31	CN¥2.70 Billion ≈ $395.32 Million	CN¥444.86 Million ≈ $65.10 Million	0.165x	+22.75%
2021-12-31	CN¥2.54 Billion ≈ $372.38 Million	CN¥341.38 Million ≈ $49.95 Million	0.134x	-8.38%
2020-12-31	CN¥2.18 Billion ≈ $319.40 Million	CN¥319.57 Million ≈ $46.76 Million	0.146x	+22.96%
2019-12-31	CN¥1.95 Billion ≈ $284.62 Million	CN¥231.60 Million ≈ $33.89 Million	0.119x	-49.11%
2018-12-31	CN¥784.05 Million ≈ $114.73 Million	CN¥183.46 Million ≈ $26.85 Million	0.234x	+175.08%
2017-12-31	CN¥580.20 Million ≈ $84.90 Million	CN¥49.35 Million ≈ $7.22 Million	0.085x	+140.25%
2016-12-31	CN¥464.98 Million ≈ $68.04 Million	CN¥-98.26 Million ≈ $-14.38 Million	-0.211x	--

About Sirio Pharma

SHE:300791 China Packaged Foods

Market Cap

$785.18 Million

CN¥5.37 Billion CNY

Market Cap Rank

#9868 Global

#2531 in China

Share Price

CN¥17.46

Change (1 day)

+1.69%

52-Week Range

CN¥15.63 - CN¥26.20

All Time High

CN¥57.47